Amgen (AMGN) To Host Conference Call To Discuss New Topline Data In Inflammation And Rare Disease

Go back to Amgen (AMGN) To Host Conference Call To Discuss New Topline Data In Inflammation And Rare Disease

AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE

September 23, 2024 4:00 PM EDT

THOUSAND OAKS, Calif., Sept. 23, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will host a webcasted call for the investment community at 1:30 p.m. PT on Tuesday, Sept. 24, 2024, to discuss new topline clinical data from the rocatinlimab (AMG 451/KHK4083) and UPLIZNA®... More